Company name: Horizon (Acquired by Amgen)

Company size: 2,000 employees

Role in this company: Reported directly to Executive Vice-President, the Executive Committee and Board, leading functional M&A and transition to Amgen ($27.8 Billion), Amgen Therapeutic Area Governance (TAG) for Rare Diseases and Global Medical Affairs function for rare disease, inflammation and immunology products.

Company name: Arena (Acquired by Pfizer)

Company size: 500 employees

Role in this company: Reported directly to the Executive Committee, leading M&A and transition with Pfizer ($6.7 Billion) and Global Medical Affairs, Health-Economics and Outcomes Research, Patient Advocacy and interim lead for safety and pharmacovigilance teams.

Company name: Sanofi

Company size: 10,000 employees

Role in this company: Attracted, hired, retained and developed a best-in-class Dupixent medical team to support the organizational goals to be a leader in Specialty Care. Established leadership in Dermatology, Respiratory, Pediatrics, ENT and Gastroenterology by collaborating with emerging and traditional KOLs, specialty physicians, payers and patients. • Led successful Dupixent medical launches in multiple indications in North America.